Fabio Nascimbeni

7.1k total citations · 5 hit papers
54 papers, 4.8k citations indexed

About

Fabio Nascimbeni is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Fabio Nascimbeni has authored 54 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 23 papers in Hepatology and 20 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Fabio Nascimbeni's work include Liver Disease Diagnosis and Treatment (40 papers), Diet, Metabolism, and Disease (20 papers) and Liver Disease and Transplantation (18 papers). Fabio Nascimbeni is often cited by papers focused on Liver Disease Diagnosis and Treatment (40 papers), Diet, Metabolism, and Disease (20 papers) and Liver Disease and Transplantation (18 papers). Fabio Nascimbeni collaborates with scholars based in Italy, France and United States. Fabio Nascimbeni's co-authors include Amedeo Lonardo, Stefano Ballestri, Giovanni Targher, Dante Romagnoli, Enrica Baldelli, Alessandro Mantovani, Vlad Ratziu, Alessandra Marrazzo, DeLisa Fairweather and Tin Aung Than and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and International Journal of Molecular Sciences.

In The Last Decade

Fabio Nascimbeni

52 papers receiving 4.7k citations

Hit Papers

Sex Differences in Nonalc... 2014 2026 2018 2022 2019 2015 2017 2017 2014 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps
    2019 688 citations Amedeo Lonardo, Fabio Nascimbeni et al. Hepatology profile →
  2. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysis
    2015 539 citations Stefano Ballestri, Giovanni Targher et al. profile →
  3. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
    2017 525 citations Amedeo Lonardo, Fabio Nascimbeni et al. Journal of Hepatology profile →
  4. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk
    2017 404 citations Stefano Ballestri, Fabio Nascimbeni et al. Advances in Therapy profile →
  5. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
    2014 350 citations Larysa Fedchuk, Fabio Nascimbeni et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabio Nascimbeni Italy 28 4.1k 2.2k 1.5k 785 639 54 4.8k
Stefano Ballestri Italy 32 4.5k 1.1× 2.3k 1.0× 1.6k 1.1× 823 1.0× 614 1.0× 54 5.3k
Shivakumar Chitturi Australia 25 4.4k 1.1× 2.1k 1.0× 1.5k 1.0× 845 1.1× 632 1.0× 40 5.5k
Romina Lomonaco United States 25 3.6k 0.9× 2.2k 1.0× 1.1k 0.8× 572 0.7× 657 1.0× 37 4.2k
Aynur Ünalp United States 17 4.1k 1.0× 2.1k 0.9× 1.7k 1.1× 616 0.8× 526 0.8× 32 4.6k
Manirath Srishord United States 13 3.6k 0.9× 1.8k 0.8× 1.6k 1.0× 668 0.9× 417 0.7× 28 4.0k
M. Marietti Italy 8 4.0k 1.0× 1.6k 0.7× 1.5k 1.0× 495 0.6× 666 1.0× 17 4.6k
James M. Paik United States 34 5.5k 1.3× 2.5k 1.1× 2.3k 1.5× 931 1.2× 937 1.5× 84 6.4k
Eduardo Vilar‐Gómez United States 26 3.9k 0.9× 1.8k 0.8× 1.9k 1.3× 582 0.7× 630 1.0× 76 4.3k
Fernando Bril United States 33 4.8k 1.2× 2.9k 1.3× 1.5k 1.0× 706 0.9× 864 1.4× 85 5.6k
Etsuko Hashimoto Japan 35 4.4k 1.1× 1.8k 0.8× 2.3k 1.5× 759 1.0× 409 0.6× 107 5.2k

Countries citing papers authored by Fabio Nascimbeni

Since Specialization
Citations

This map shows the geographic impact of Fabio Nascimbeni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Nascimbeni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Nascimbeni more than expected).

Fields of papers citing papers by Fabio Nascimbeni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabio Nascimbeni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Nascimbeni. The network helps show where Fabio Nascimbeni may publish in the future.

Co-authorship network of co-authors of Fabio Nascimbeni

This figure shows the co-authorship network connecting the top 25 collaborators of Fabio Nascimbeni. A scholar is included among the top collaborators of Fabio Nascimbeni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio Nascimbeni. Fabio Nascimbeni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Motta, Irene, Lorena Duca, Fabio Nascimbeni, et al.. (2024). Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease. Annals of Hematology. 103(12). 5113–5121. 1 indexed citations
2.
Gabrielli, Filippo, et al.. (2024). Metabolic Disorders in Liver Transplant Recipients: The State of the Art. Journal of Clinical Medicine. 13(4). 1014–1014. 9 indexed citations
3.
Croci, Giorgio Alberto, Elena Cassinerio, Alessia Marcon, et al.. (2022). Splenomegaly: Dare to think rare. American Journal of Hematology. 97(9). 1259–1265. 1 indexed citations
4.
Nascimbeni, Fabio, et al.. (2021). A case of statin-induced liver injury with positive rechallenge with a second statin. Is there a class effect?. Journal of Basic and Clinical Physiology and Pharmacology. 32(6). 1151–1155. 1 indexed citations
5.
Greco, Carla, Fabio Nascimbeni, Francesca Carubbi, et al.. (2021). Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Peripheral Diabetic Polyneuropathy: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 10(19). 4466–4466. 9 indexed citations
6.
Lonardo, Amedeo, Fabio Nascimbeni, Stefano Ballestri, et al.. (2019). Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps. Hepatology. 70(4). 1457–1469. 688 indexed citations breakdown →
7.
Ballestri, Stefano, Alessandro Mantovani, Fabio Nascimbeni, Simonetta Lugari, & Amedeo Lonardo. (2019). Extra-Hepatic Manifestations and Complications of Nonalcoholic Fatty Liver Disease. Future Medicinal Chemistry. 11(16). 2171–2192. 31 indexed citations
8.
Nascimbeni, Fabio, et al.. (2019). Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes. Atherosclerosis. 284. 66–74. 60 indexed citations
9.
Ballestri, Stefano, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo, & Giampiero Francica. (2019). A critical appraisal of the use of ultrasound in hepatic steatosis. Expert Review of Gastroenterology & Hepatology. 13(7). 667–681. 40 indexed citations
10.
Lugari, Simonetta, Alessandro Mantovani, Fabio Nascimbeni, & Amedeo Lonardo. (2018). Hypothyroidism and nonalcoholic fatty liver disease – a chance association?. Hormone Molecular Biology and Clinical Investigation. 41(1). 26 indexed citations
11.
Lonardo, Amedeo, Simonetta Lugari, Stefano Ballestri, et al.. (2018). A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?. Acta Diabetologica. 56(4). 385–396. 77 indexed citations
12.
Nascimbeni, Fabio, Elena Cassinerio, Irene Motta, et al.. (2018). Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease. Molecular Genetics and Metabolism. 125(1-2). 64–72. 22 indexed citations
13.
Lonardo, Amedeo, Fabio Nascimbeni, Alessandro Mantovani, & Giovanni Targher. (2017). Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?. Journal of Hepatology. 68(2). 335–352. 525 indexed citations breakdown →
14.
Rinaldi, Luca, Fabio Nascimbeni, Mauro Giordano, et al.. (2017). Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. World Journal of Gastroenterology. 23(8). 1458–1458. 36 indexed citations
15.
Lonardo, Amedeo, Fabio Nascimbeni, Giovanni Targher, et al.. (2017). AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. Digestive and Liver Disease. 49(5). 471–483. 244 indexed citations
16.
Ballestri, Stefano, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, & Amedeo Lonardo. (2016). The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans. Advances in Therapy. 33(3). 291–319. 63 indexed citations
17.
Nascimbeni, Fabio, Paola Loria, & Vlad Ratziu. (2014). Non-Alcoholic Fatty Liver Disease: Diagnosis and Investigation. Digestive Diseases. 32(5). 586–596. 6 indexed citations
18.
Nascimbeni, Fabio, Pascal Lebray, Larysa Fedchuk, et al.. (2014). Significant Variations in Elastometry Measurements Made Within Short-term in Patients With Chronic Liver Diseases. Clinical Gastroenterology and Hepatology. 13(4). 763–771.e6. 57 indexed citations
19.
Carulli, Lucia, Alessandra Dei, & Fabio Nascimbeni. (2012). Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis: A clue to telomere involvement. Hepatology. 56(5). 2001–2003. 17 indexed citations
20.
Gangi, P. Di, et al.. (2009). Role of Multidrug-Resistance Protein 2 in coproporphyrin transport: results from experimental studies in bile fistula rat models.. PubMed. 55(2). 70–8. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefano Ballestri Breakdown of academic impact, for papers by Shivakumar Chitturi Breakdown of academic impact, for papers by Romina Lomonaco Breakdown of academic impact, for papers by Aynur Ünalp Breakdown of academic impact, for papers by Manirath Srishord Breakdown of academic impact, for papers by M. Marietti Breakdown of academic impact, for papers by James M. Paik Breakdown of academic impact, for papers by Eduardo Vilar‐Gómez Breakdown of academic impact, for papers by Fernando Bril Breakdown of academic impact, for papers by Etsuko Hashimoto
Rankless by CCL
2026